Alembic Pharma announces US FDA tentative approval for Dabigatran Etexilate capsules EP News Bureau Apr 7, 2022 The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Pradaxa capsules, 75 mg,…
Glenmark Pharma gets ANDA tentative approval for Dabigatran Etexilate Capsules EP News Bureau Dec 21, 2020 It is the generic version of Pradaxa Capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim
